Matinas BioPharma Board Approves 1-For-15 Reverse Stock Split Effective September 28, 2026
On June 23, 2025, at the 2025 annual meeting of stockholders of Matinas BioPharma Holdings, Inc. (the "Company"), the stockholders approved the authorization of the Board of Directors (the "Board"), in its sole and absolute discretion and without further stockholder approval, to effect up to two reverse stock splits of